Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Chongqing Ruien Pharmaceutical is a comprehensive pharmaceutical enterprise based in Chongqing, China, specializing in the research, development, and manufacturing of chemical drugs and active pharmaceutical ingredients (APIs). The company operates state-of-the-art GMP-certified production facilities that produce a variety of dosage forms, including tablets, capsules, and sterile injections. Its product portfolio primarily focuses on high-demand therapeutic areas such as cardiovascular health, anti-infectives, and gastrointestinal disorders. Ruien Pharmaceutical integrates its R&D capabilities with large-scale manufacturing to supply both the domestic Chinese market and international clients. The company is recognized for its commitment to quality control and technological advancement in the production of essential generic medicines.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Chongqing Ruien Pharmaceutical.